ATAZANAVIR

ATAZANAVIR was reported 14306 times

ATAZANAVIR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SUPERNUMERARY NIPPLE 26 0.3171
1 CONGENITAL NAEVUS 45 0.3169
2 AIDS ENCEPHALOPATHY 15 0.2586
3 HIV WASTING SYNDROME 9 0.2500
4 CSF HIV ESCAPE SYNDROME 29 0.2101
5 ACOUSTIC STIMULATION TESTS ABNORMAL 29 0.1859
6 AIDS DEMENTIA COMPLEX 10 0.1639
7 ALPHA 1 FOETOPROTEIN ABNORMAL 16 0.1600
8 CONGENITAL HEPATOMEGALY 7 0.1591
9 PRENATAL SCREENING TEST ABNORMAL 8 0.1481
10 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA 16 0.1240
11 PULMONARY HAEMORRHAGE NEONATAL 11 0.1196
12 MITOCHONDRIAL TOXICITY 95 0.1157
13 CONGENITAL BOWING OF LONG BONES 9 0.1111
14 LIPODYSTROPHY ACQUIRED 236 0.1111
15 ULTRASOUND ANTENATAL SCREEN ABNORMAL 24 0.1091
16 CONGENITAL TERATOMA 9 0.1047
17 HETEROTAXIA 17 0.1018
18 HIV-ASSOCIATED NEUROCOGNITIVE DISORDER 11 0.0991
19 BONE DEMINERALISATION 104 0.0982
20 BLOOD ANTIDIURETIC HORMONE INCREASED 9 0.0968
21 PSYCHIATRIC DECOMPENSATION 179 0.0915
22 CUSHING'S SYNDROME 61 0.0878
23 LOW SET EARS 35 0.0852
24 CHORDEE 12 0.0851
25 HYPERCORTICOIDISM 9 0.0849
26 RENAL DYSPLASIA 29 0.0749
27 RETINOBLASTOMA 8 0.0734
28 FOETAL CHROMOSOME ABNORMALITY 12 0.0706
29 BLOOD BILIRUBIN UNCONJUGATED INCREASED 51 0.0702
30 SINGLE UMBILICAL ARTERY 25 0.0678
31 CONGENITAL PYELOCALIECTASIS 8 0.0667
32 RENAL COLIC 150 0.0663
33 NEONATAL HYPONATRAEMIA 8 0.0656
34 ERGOT POISONING 8 0.0640
35 CONGENITAL HYDROCEPHALUS 30 0.0592
36 CONGENITAL CYSTIC LUNG 7 0.0583
37 PLACENTAL INFARCTION 13 0.0583
38 IMMUNE RECONSTITUTION SYNDROME 75 0.0581
39 KAPOSI'S SARCOMA 29 0.0578
40 FANCONI SYNDROME ACQUIRED 101 0.0575
41 CRYSTAL URINE 9 0.0563
42 VIROLOGIC FAILURE 300 0.0557
43 TRISOMY 18 21 0.0551
44 PSYCHOMOTOR SKILLS IMPAIRED 143 0.0545
45 HIGH ARCHED PALATE 9 0.0526
46 FACIAL WASTING 14 0.0520
47 GENITALIA EXTERNAL AMBIGUOUS 9 0.0520
48 CONGENITAL SKIN DIMPLES 12 0.0498
49 NEONATAL SEIZURE 12 0.0482
50 CALCULUS URINARY 73 0.0474
51 PERIVENTRICULAR LEUKOMALACIA 13 0.0459
52 DEPRESSION SUICIDAL 158 0.0456
53 MITOCHONDRIAL CYTOPATHY 20 0.0455
54 LIPOATROPHY 43 0.0452
55 RENAL TUBULAR DYSFUNCTION 25 0.0442
56 RENAL TUBULAR DISORDER 124 0.0440
57 TRISOMY 21 55 0.0437
58 FAT REDISTRIBUTION 10 0.0431
59 DEPRESSIVE SYMPTOM 152 0.0431
60 LEFT VENTRICULAR DILATATION 22 0.0431
61 HAEMOPHILIC ARTHROPATHY 10 0.0418
62 VENTRICULAR HYPOPLASIA 10 0.0400
63 UMBILICAL CORD ABNORMALITY 21 0.0398
64 ADRENAL SUPPRESSION 33 0.0391
65 VIRAL MUTATION IDENTIFIED 139 0.0377
66 HYPERBILIRUBINAEMIA 389 0.0375
67 BLOOD CORTISOL DECREASED 24 0.0375
68 BLOOD HIV RNA INCREASED 68 0.0375
69 FANCONI SYNDROME 53 0.0375
70 PORTAL FIBROSIS 8 0.0374
71 ACUTE HIV INFECTION 9 0.0364
72 TEARFULNESS 156 0.0362
73 NEURAL TUBE DEFECT 26 0.0358
74 PLACENTAL INSUFFICIENCY 28 0.0349
75 ACQUIRED IMMUNODEFICIENCY SYNDROME 18 0.0347
76 HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION 12 0.0334
77 PLACENTA PRAEVIA 26 0.0331
78 TWIN PREGNANCY 27 0.0321
79 LIMB MALFORMATION 24 0.0304
80 GLYCOSURIA 41 0.0303
81 INTESTINAL MALROTATION 8 0.0303
82 SINGLE FUNCTIONAL KIDNEY 20 0.0302
83 CRANIOFACIAL DEFORMITY 7 0.0300
84 CONGENITAL HEART VALVE DISORDER 7 0.0294
85 STILLBIRTH 142 0.0294
86 GENOTYPE DRUG RESISTANCE TEST POSITIVE 30 0.0292
87 BLOOD CORTICOTROPHIN DECREASED 14 0.0287
88 ANOMALOUS PULMONARY VENOUS CONNECTION 7 0.0286
89 RENAL APLASIA 20 0.0284
90 VIRAL LOAD INCREASED 110 0.0283
91 CHOLESTASIS OF PREGNANCY 13 0.0283
92 CD4 LYMPHOCYTES DECREASED 58 0.0271
93 POLYDACTYLY 31 0.0267
94 PREGNANCY ON CONTRACEPTIVE 39 0.0267
95 ANENCEPHALY 15 0.0265
96 POLYHYDRAMNIOS 27 0.0264
97 CALCULUS URETERIC 19 0.0262
98 HYPERBILIRUBINAEMIA NEONATAL 15 0.0258
99 MACROCEPHALY 10 0.0258
100 ULTRASOUND SCAN ABNORMAL 10 0.0255
101 FOETAL CARDIAC DISORDER 8 0.0253
102 CONGENITAL HYDRONEPHROSIS 18 0.0252
103 NODULAR REGENERATIVE HYPERPLASIA 16 0.0249
104 SKULL MALFORMATION 16 0.0249
105 OPHTHALMOPLEGIA 38 0.0241
106 MONONEUROPATHY MULTIPLEX 11 0.0238
107 BILIRUBIN CONJUGATED INCREASED 54 0.0231
108 OCULAR ICTERUS 100 0.0230
109 BLIGHTED OVUM 9 0.0229
110 LIVE BIRTH 191 0.0228
111 INTRAVENTRICULAR HAEMORRHAGE NEONATAL 11 0.0226
112 ANHEDONIA 593 0.0225
113 SPINA BIFIDA 47 0.0225
114 LIPOHYPERTROPHY 14 0.0225
115 EXOMPHALOS 12 0.0223
116 PREMATURE RUPTURE OF MEMBRANES 52 0.0215
117 ABORTION INDUCED 201 0.0213
118 BENIGN HYDATIDIFORM MOLE 7 0.0211
119 BACTERIAL PYELONEPHRITIS 7 0.0208
120 SYPHILIS 15 0.0206
121 CYTOGENETIC ABNORMALITY 23 0.0204
122 CEREBRAL TOXOPLASMOSIS 19 0.0203
123 CHRONIC HEPATITIS C 8 0.0203
124 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 21 0.0194
125 CYSTITIS NONINFECTIVE 26 0.0194
126 HEPATITIS B DNA INCREASED 13 0.0193
127 PSYCHOMOTOR RETARDATION 54 0.0192
128 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 93 0.0186
129 HYPERSPLENISM 9 0.0182
130 AMYOTROPHY 7 0.0181
131 AMNIOTIC CAVITY INFECTION 13 0.0180
132 ANOGENITAL WARTS 16 0.0179
133 FOETAL EXPOSURE DURING DELIVERY 12 0.0177
134 ENANTHEMA 10 0.0174
135 EAR MALFORMATION 8 0.0173
136 PLACENTAL DISORDER 16 0.0169
137 SYNDACTYLY 14 0.0168
138 ECONOMIC PROBLEM 255 0.0168
139 PNEUMOCOCCAL SEPSIS 11 0.0167
140 FOETAL GROWTH RETARDATION 13 0.0166
141 NEPHRITIS INTERSTITIAL 21 0.0166
142 LOW BIRTH WEIGHT BABY 132 0.0166
143 OSTEOMALACIA 25 0.0162
144 NEPHROCALCINOSIS 19 0.0160
145 ENCEPHALOMALACIA 9 0.0160
146 CYTOLYTIC HEPATITIS 52 0.0156
147 PLEOCYTOSIS 9 0.0155
148 CONGENITAL FOOT MALFORMATION 7 0.0154
149 VANISHING BILE DUCT SYNDROME 17 0.0152
150 CONGENITAL NOSE MALFORMATION 8 0.0150
151 FOETAL GROWTH RESTRICTION 91 0.0150
152 HYDROPS FOETALIS 9 0.0147
153 T-LYMPHOCYTE COUNT DECREASED 10 0.0147
154 COARCTATION OF THE AORTA 14 0.0145
155 OSTEOPENIA 219 0.0144
156 OESOPHAGEAL ATRESIA 9 0.0144
157 CYTOMEGALOVIRUS CHORIORETINITIS 28 0.0143
158 NORMAL NEWBORN 78 0.0143
159 PATHOGEN RESISTANCE 130 0.0142
160 FOETAL HEART RATE ABNORMAL 13 0.0140
161 HIV INFECTION 42 0.0139
162 CSF TEST ABNORMAL 7 0.0139
163 SECONDARY ADRENOCORTICAL INSUFFICIENCY 21 0.0139
164 CEREBRAL VENTRICLE DILATATION 16 0.0139
165 HODGKIN'S DISEASE 10 0.0138
166 BLOOD BILIRUBIN INCREASED 371 0.0137
167 JAUNDICE 367 0.0136
168 CENTRAL OBESITY 10 0.0135
169 FOETAL DEATH 69 0.0133
170 MICROCEPHALY 17 0.0133
171 FOETAL DISTRESS SYNDROME 28 0.0132
172 ANAL ATRESIA 7 0.0131
173 FOETAL EXPOSURE DURING PREGNANCY 1042 0.0128
174 ABORTION SPONTANEOUS 513 0.0128
175 WHITE MATTER LESION 16 0.0127
176 JARISCH-HERXHEIMER REACTION 9 0.0126
177 PATENT DUCTUS ARTERIOSUS 50 0.0126
178 CAESAREAN SECTION 145 0.0124
179 FAT TISSUE INCREASED 18 0.0124
180 VENTRICULAR SEPTAL DEFECT 71 0.0124
181 BREAST DISORDER 25 0.0122
182 PREMATURE DELIVERY 193 0.0121
183 RENAL ATROPHY 15 0.0120
184 PORTAL HYPERTENSION 37 0.0120
185 PRURIGO 11 0.0119
186 PREMATURE BABY 357 0.0118
187 CRYSTAL NEPHROPATHY 7 0.0118
188 HEART TRANSPLANT REJECTION 12 0.0116
189 TRANSPOSITION OF THE GREAT VESSELS 9 0.0115
190 PYELOCALIECTASIS 11 0.0115
191 CLEFT LIP 10 0.0114
192 MALARIA 8 0.0113
193 DRUG INTERACTION 1791 0.0113
194 EYELID PTOSIS 110 0.0108
195 RETINAL TOXICITY 11 0.0107
196 ENCEPHALITIS VIRAL 13 0.0107
197 RENAL TUBULAR ACIDOSIS 23 0.0105
198 MALIGNANT HYPERTENSION 9 0.0105
199 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 34 0.0105
200 CONDUCTION DISORDER 19 0.0104
201 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 11 0.0104
202 NEPHROLITHIASIS 474 0.0103
203 PNEUMOCYSTIS JIROVECI PNEUMONIA 23 0.0103
204 ANAL CANCER 10 0.0103
205 DEATH NEONATAL 14 0.0101
206 BLOOD LACTIC ACID INCREASED 53 0.0101
207 PARANOIA 170 0.0099
208 OSTEOPOROSIS 400 0.0097
209 MYCOBACTERIUM AVIUM COMPLEX INFECTION 26 0.0097
210 CEREBRAL PALSY 9 0.0095
211 OLIGOHYDRAMNIOS 31 0.0093
212 BONE MARROW TOXICITY 11 0.0093
213 PERIPHERAL MOTOR NEUROPATHY 13 0.0093
214 TOXOPLASMOSIS 10 0.0093
215 HYPERTRIGLYCERIDAEMIA 54 0.0092
216 MYOGLOBIN BLOOD INCREASED 14 0.0092
217 DRUG RESISTANCE 234 0.0091
218 PREMATURE SEPARATION OF PLACENTA 14 0.0091
219 SEBORRHOEIC DERMATITIS 15 0.0091
220 ELECTROCARDIOGRAM QT CORRECTED INTERVAL PROLONGED 7 0.0089
221 CRYPTORCHISM 10 0.0089
222 ARTERIAL DISORDER 17 0.0089
223 SMALL FOR DATES BABY 44 0.0089
224 OROPHARYNGEAL CANDIDIASIS 8 0.0088
225 BONE DENSITY DECREASED 275 0.0088
226 BRONCHOPULMONARY DYSPLASIA 7 0.0087
227 HAEMOCHROMATOSIS 8 0.0087
228 MATERNAL EXPOSURE DURING PREGNANCY 754 0.0085
229 BRADYCARDIA FOETAL 7 0.0084
230 PRE-ECLAMPSIA 40 0.0084
231 INTUSSUSCEPTION 8 0.0084
232 CONGENITAL CYSTIC KIDNEY DISEASE 7 0.0083
233 ECTOPIC PREGNANCY 25 0.0081
234 HYPOPHOSPHATAEMIA 60 0.0081
235 CUSHINGOID 26 0.0081
236 PREGNANCY 158 0.0079
237 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 377 0.0078
238 GESTATIONAL DIABETES 37 0.0078
239 CLEFT PALATE 15 0.0078
240 PROTEINURIA 147 0.0077
241 GLOMERULONEPHRITIS MEMBRANOUS 9 0.0077
242 FEEDING DISORDER NEONATAL 8 0.0076
243 NEONATAL RESPIRATORY DISTRESS SYNDROME 27 0.0076
244 DRUG EXPOSURE DURING PREGNANCY 259 0.0076
245 BLOOD AMYLASE INCREASED 13 0.0076
246 INTRA-UTERINE DEATH 12 0.0075
247 MENINGITIS CRYPTOCOCCAL 13 0.0074
248 PREMATURE LABOUR 42 0.0074
249 JAUNDICE NEONATAL 14 0.0074
250 FOETAL MALFORMATION 8 0.0074
251 DYSLIPIDAEMIA 37 0.0073
252 VARICES OESOPHAGEAL 22 0.0073
253 VIRAEMIA 10 0.0072
254 CARDIAC HYPERTROPHY 8 0.0072
255 CLEFT LIP AND PALATE 8 0.0072
256 DILATATION VENTRICULAR 15 0.0071
257 GLUCOSE URINE PRESENT 9 0.0071
258 HYDRONEPHROSIS 53 0.0071
259 HEART DISEASE CONGENITAL 25 0.0071
260 BLOOD BILIRUBIN ABNORMAL 9 0.0070
261 OESOPHAGEAL CANDIDIASIS 28 0.0070
262 DYSMORPHISM 16 0.0068
263 OSTEOPOROTIC FRACTURE 13 0.0068
264 MULTIPLE-DRUG RESISTANCE 21 0.0068
265 PSYCHOTIC DISORDER 199 0.0067
266 ATRIOVENTRICULAR BLOCK FIRST DEGREE 29 0.0067
267 PYELONEPHRITIS ACUTE 13 0.0066
268 DERMATITIS EXFOLIATIVE GENERALISED 23 0.0066
269 UNDERWEIGHT 13 0.0066
270 CELL DEATH 13 0.0065
271 OSTEONECROSIS 215 0.0065
272 NEPHROPATHY TOXIC 72 0.0064
273 GASTROINTESTINAL TUBE INSERTION 16 0.0064
274 BREECH PRESENTATION 8 0.0064
275 RENAL TUBULAR NECROSIS 61 0.0062
276 MULTIPLE FRACTURES 102 0.0062
277 GESTATIONAL HYPERTENSION 8 0.0062
278 BILIARY COLIC 18 0.0062
279 CORTISOL DECREASED 7 0.0061
280 FOLATE DEFICIENCY 7 0.0061
281 HYDROCEPHALUS 33 0.0061
282 SKIN STRIAE 9 0.0060
283 CEREBRAL ISCHAEMIA 31 0.0060
284 OESOPHAGEAL VARICES HAEMORRHAGE 13 0.0060
285 HYPERCAPNIA 18 0.0060
286 END STAGE RENAL DISEASE 108 0.0059
287 RENAL FAILURE ACUTE 250 0.0059
288 BONE LOSS 88 0.0058
289 HEPATOSPLENOMEGALY 15 0.0058
290 HYPERURICAEMIA 24 0.0058
291 DEPRESSION 1320 0.0058
292 HYPOTONIA NEONATAL 9 0.0058
293 DECREASED ACTIVITY 62 0.0057
294 IDIOPATHIC THROMBOCYTOPENIC PURPURA 9 0.0057
295 EXPOSURE DURING PREGNANCY 352 0.0057
296 ATYPICAL MYCOBACTERIAL INFECTION 8 0.0057
297 HEPATITIS C 68 0.0056
298 PORTAL VEIN THROMBOSIS 18 0.0056
299 HYPOTHALAMO-PITUITARY DISORDER 8 0.0055
300 EMOTIONAL DISTRESS 651 0.0054
301 CONGENITAL ANOMALY 41 0.0053
302 HYPOSPADIAS 11 0.0053
303 CHRONIC KIDNEY DISEASE 401 0.0053
304 CACHEXIA 27 0.0052
305 SPEECH DISORDER DEVELOPMENTAL 15 0.0052
306 MYCOBACTERIAL INFECTION 9 0.0052
307 HEPATIC NEOPLASM MALIGNANT 11 0.0052
308 HYPERPARATHYROIDISM SECONDARY 13 0.0052
309 VASCULAR RUPTURE 8 0.0052
310 TALIPES 16 0.0051
311 ENCEPHALITIS 35 0.0051
312 CYTOMEGALOVIRUS TEST POSITIVE 9 0.0050
313 QUALITY OF LIFE DECREASED 67 0.0050
314 WRONG DOSE 12 0.0050
315 MATERNAL DRUGS AFFECTING FOETUS 38 0.0050
316 GLOMERULAR FILTRATION RATE ABNORMAL 7 0.0049
317 BLOOD PHOSPHORUS DECREASED 18 0.0049
318 HYPERLACTACIDAEMIA 13 0.0048
319 NEPHROPATHY 45 0.0048
320 VITAMIN D DEFICIENCY 47 0.0048
321 STRABISMUS 14 0.0048
322 ANAEMIA MACROCYTIC 10 0.0047
323 HEPATITIS B 28 0.0046
324 KIDNEY FIBROSIS 8 0.0046
325 NASAL SEPTUM DEVIATION 9 0.0046
326 CEREBELLAR SYNDROME 10 0.0046
327 LYMPHADENITIS 11 0.0045
328 GASTROSTOMY 7 0.0045
329 HEPATOMEGALY 44 0.0045
330 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 36 0.0044
331 HEPATITIS 111 0.0043
332 DYSENTERY 8 0.0043
333 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 38 0.0043
334 TOOTH LOSS 88 0.0042
335 HEPATITIS TOXIC 11 0.0042
336 TOXIC SKIN ERUPTION 42 0.0042
337 DRUG LEVEL INCREASED 69 0.0042
338 PYELONEPHRITIS 36 0.0042
339 RENAL TRANSPLANT 15 0.0041
340 HYPERLIPIDAEMIA 49 0.0041
341 BILE DUCT STONE 13 0.0041
342 APLASIA 8 0.0041
343 YELLOW SKIN 19 0.0041
344 CARDIAC MURMUR 35 0.0040
345 ADRENAL INSUFFICIENCY 49 0.0040
346 HAEMOLYTIC ANAEMIA 36 0.0040
347 CHOLESTASIS 76 0.0040
348 BLOOD CREATININE INCREASED 254 0.0039
349 HYPERPARATHYROIDISM 8 0.0039
350 EOSINOPHILIA 67 0.0038
351 HEPATOCELLULAR INJURY 54 0.0038
352 HEPATIC FIBROSIS 13 0.0038
353 GLOMERULAR FILTRATION RATE DECREASED 46 0.0037
354 PRESCRIBED OVERDOSE 71 0.0037
355 CLAVICLE FRACTURE 14 0.0037
356 RENAL IMPAIRMENT 303 0.0036
357 ALCOHOL INTERACTION 7 0.0036
358 ATRIAL SEPTAL DEFECT 30 0.0036
359 RENAL FAILURE 474 0.0036
360 GENE MUTATION 7 0.0035
361 HUMERUS FRACTURE 17 0.0035
362 CANDIDIASIS 14 0.0035
363 MYOSITIS 31 0.0035
364 TUMOUR LYSIS SYNDROME 30 0.0034
365 DIPLOPIA 88 0.0034
366 SPINAL COMPRESSION FRACTURE 28 0.0034
367 CHOLELITHIASIS 110 0.0034
368 BUNDLE BRANCH BLOCK LEFT 14 0.0033
369 HEPATIC CIRRHOSIS 62 0.0033
370 ATRIOVENTRICULAR BLOCK COMPLETE 22 0.0033
371 BLOOD ALKALINE PHOSPHATASE INCREASED 81 0.0033
372 ALANINE AMINOTRANSFERASE INCREASED 200 0.0033
373 DRUG SCREEN FALSE POSITIVE 9 0.0032
374 TRANSAMINASES INCREASED 72 0.0032
375 GASTRIC BYPASS 7 0.0032
376 RETINOPATHY 12 0.0032
377 INTRAVENTRICULAR HAEMORRHAGE 8 0.0032
378 HAEMATURIA 110 0.0032
379 HYPERCHOLESTEROLAEMIA 31 0.0032
380 VENTRICULAR HYPERTROPHY 8 0.0032
381 ACUTE LYMPHOCYTIC LEUKAEMIA 9 0.0032
382 PATHOLOGICAL FRACTURE 16 0.0031
383 NEUROLOGICAL SYMPTOM 18 0.0031
384 LEFT VENTRICULAR DYSFUNCTION 21 0.0031
385 EXERCISE TOLERANCE DECREASED 18 0.0031
386 ASPARTATE AMINOTRANSFERASE INCREASED 166 0.0031
387 RENAL FAILURE CHRONIC 24 0.0031
388 BLOOD TRIGLYCERIDES INCREASED 55 0.0031
389 DISTRIBUTIVE SHOCK 7 0.0031
390 SPLENOMEGALY 36 0.0031
391 NEPHROTIC SYNDROME 21 0.0031
392 TORSADE DE POINTES 24 0.0031
393 ANXIETY 867 0.0030
394 PULMONARY TUBERCULOSIS 13 0.0030
395 ORAL CANDIDIASIS 40 0.0030
396 APHTHOUS STOMATITIS 7 0.0030
397 NEPHROGENIC ANAEMIA 14 0.0030
398 PROTEIN URINE PRESENT 15 0.0030
399 NEPHRITIS 10 0.0030
400 PARKINSONISM 29 0.0030
401 HEPATIC STEATOSIS 55 0.0029
402 BLOOD PHOSPHORUS INCREASED 8 0.0029
403 FEMORAL NECK FRACTURE 15 0.0029
404 HERPES SIMPLEX 19 0.0029
405 HEPATITIS ACUTE 19 0.0029
406 WRIST FRACTURE 35 0.0029
407 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 50 0.0029
408 ANKLE FRACTURE 45 0.0029
409 BENIGN PROSTATIC HYPERPLASIA 15 0.0029
410 BLOOD CREATININE ABNORMAL 10 0.0029
411 HAND FRACTURE 20 0.0028
412 HEPATITIS CHOLESTATIC 17 0.0028
413 GAMMA-GLUTAMYLTRANSFERASE INCREASED 62 0.0028
414 CORONARY ARTERY STENOSIS 14 0.0028
415 ABORTION 8 0.0027
416 TUBULOINTERSTITIAL NEPHRITIS 51 0.0027
417 SKELETAL INJURY 28 0.0027
418 DRUG LEVEL DECREASED 27 0.0027
419 APLASIA PURE RED CELL 9 0.0026
420 TREATMENT NONCOMPLIANCE 143 0.0026
421 ACUTE MYOCARDIAL INFARCTION 77 0.0026
422 FIBROSIS 8 0.0026
423 AUTOIMMUNE HEPATITIS 18 0.0026
424 ANOREXIA 33 0.0026
425 CLONUS 7 0.0026
426 ELECTROENCEPHALOGRAM ABNORMAL 8 0.0025
427 POLYDIPSIA 10 0.0025
428 ODYNOPHAGIA 15 0.0025
429 CREATININE RENAL CLEARANCE DECREASED 10 0.0025
430 FACE OEDEMA 42 0.0025
431 FOOT FRACTURE 47 0.0025
432 ILEUS PARALYTIC 11 0.0025
433 CHOLECYSTITIS 29 0.0024
434 HEPATOTOXICITY 54 0.0024
435 SUICIDAL IDEATION 221 0.0024
436 BONE DENSITY ABNORMAL 9 0.0024
437 CONGESTIVE CARDIOMYOPATHY 10 0.0024
438 BLOOD CREATINE PHOSPHOKINASE INCREASED 69 0.0024
439 POTENTIATING DRUG INTERACTION 8 0.0024
440 LIPASE INCREASED 18 0.0023
441 TIBIA FRACTURE 11 0.0023
442 ATRIOVENTRICULAR BLOCK SECOND DEGREE 7 0.0023
443 STAPHYLOCOCCAL BACTERAEMIA 10 0.0023
444 DYSAESTHESIA 7 0.0023
445 FRACTURE 43 0.0023
446 RASH MACULO-PAPULAR 49 0.0022
447 LOW DENSITY LIPOPROTEIN INCREASED 17 0.0022
448 PANCREATITIS ACUTE 49 0.0022
449 TRICUSPID VALVE INCOMPETENCE 17 0.0021
450 LIVER FUNCTION TEST ABNORMAL 61 0.0021
451 METABOLIC ACIDOSIS 67 0.0021
452 POLYNEUROPATHY 25 0.0021
453 MULTI-ORGAN FAILURE 36 0.0021
454 PERIPHERAL SENSORY NEUROPATHY 12 0.0021
455 RASH GENERALISED 53 0.0020
456 HEPATIC ENCEPHALOPATHY 19 0.0020
457 ELECTROCARDIOGRAM QT PROLONGED 73 0.0020
458 GLUCOSE TOLERANCE IMPAIRED 12 0.0020
459 BLOOD LACTATE DEHYDROGENASE INCREASED 32 0.0020
460 RHABDOMYOLYSIS 84 0.0020
461 AZOTAEMIA 8 0.0020
462 LACTIC ACIDOSIS 64 0.0020
463 DRUG LEVEL ABOVE THERAPEUTIC 9 0.0020
464 IRON DEFICIENCY ANAEMIA 18 0.0019
465 HAEMOLYSIS 15 0.0019
466 CHOLECYSTITIS ACUTE 11 0.0019
467 LYMPHOMA 30 0.0019
468 LIVER DISORDER 86 0.0019
469 RENAL INJURY 57 0.0019
470 BLOOD URIC ACID INCREASED 11 0.0019
471 SLEEP TERROR 8 0.0019
472 EYELID OEDEMA 22 0.0019
473 NYSTAGMUS 10 0.0019
474 ACUTE KIDNEY INJURY 288 0.0019
475 HEPATIC FAILURE 56 0.0019
476 RIB FRACTURE 38 0.0018
477 ANAEMIA 349 0.0018
478 STAPHYLOCOCCAL SEPSIS 9 0.0018
479 DYSSTASIA 53 0.0018
480 FLANK PAIN 17 0.0018
481 ARTERIOSCLEROSIS CORONARY ARTERY 12 0.0018
482 DERMATITIS EXFOLIATIVE 9 0.0018
483 PNEUMOCYSTIS JIROVECII PNEUMONIA 18 0.0018
484 HAEMATOTOXICITY 17 0.0018
485 CARDIOMEGALY 22 0.0018
486 PANCYTOPENIA 99 0.0018
487 SPINAL FRACTURE 35 0.0017
488 BUNDLE BRANCH BLOCK RIGHT 8 0.0017
489 DYSPHAGIA 164 0.0017
490 APLASTIC ANAEMIA 9 0.0017
491 HEPATIC FUNCTION ABNORMAL 64 0.0017
492 POLYURIA 14 0.0017
493 HYPOTONIA 17 0.0017
494 RENAL PAIN 18 0.0017
495 MYOCLONUS 20 0.0017
496 HAEMODIALYSIS 14 0.0017
497 NERVOUS SYSTEM DISORDER 52 0.0017
498 AFFECT LABILITY 16 0.0017
499 TYPE 1 DIABETES MELLITUS 10 0.0017
500 ESCHERICHIA URINARY TRACT INFECTION 7 0.0016
501 AORTIC VALVE INCOMPETENCE 7 0.0016
502 ASCITES 48 0.0016
503 RENAL DISORDER 76 0.0016
504 ANURIA 14 0.0016
505 LYMPHADENOPATHY 57 0.0016
506 ABNORMAL FAECES 13 0.0016
507 BLOOD CREATINE INCREASED 7 0.0016
508 GASTROENTERITIS 23 0.0016
509 HYPERTHERMIA 12 0.0016
510 PANCREATITIS 83 0.0016
511 DISSEMINATED INTRAVASCULAR COAGULATION 22 0.0016
512 DEVELOPMENTAL DELAY 14 0.0016
513 SINUS BRADYCARDIA 15 0.0016
514 MITRAL VALVE INCOMPETENCE 17 0.0015
515 APPENDICITIS 14 0.0015
516 POST-TRAUMATIC STRESS DISORDER 10 0.0015
517 PSYCHIATRIC SYMPTOM 11 0.0015
518 ACUTE HEPATIC FAILURE 20 0.0015
519 SUPRAVENTRICULAR TACHYCARDIA 14 0.0015
520 AUTISM SPECTRUM DISORDER 8 0.0015
521 CHOLANGITIS 9 0.0015
522 HEPATOCELLULAR CARCINOMA 11 0.0014
523 BLOOD UREA INCREASED 24 0.0014
524 ATRIOVENTRICULAR BLOCK 11 0.0014
525 DIABETES MELLITUS 108 0.0014
526 DRUG ERUPTION 25 0.0014
527 SINUS TACHYCARDIA 20 0.0014
528 INTERVERTEBRAL DISC DEGENERATION 13 0.0014
529 UVEITIS 19 0.0014
530 HERPES VIRUS INFECTION 8 0.0014
531 METABOLIC DISORDER 8 0.0014
532 BONE DISORDER 25 0.0014
533 SOMNAMBULISM 9 0.0014
534 GASTRIC ULCER 26 0.0014
535 ORAL DISORDER 10 0.0014
536 DIALYSIS 19 0.0013
537 HEMIPLEGIA 11 0.0013
538 HIATUS HERNIA 17 0.0013
539 HIP ARTHROPLASTY 20 0.0013
540 HYPOKALAEMIA 60 0.0013
541 HYPOTHERMIA 13 0.0013
542 BONE MARROW FAILURE 26 0.0013
543 ARTERIOSCLEROSIS 12 0.0013
544 MYOPATHY 11 0.0013
545 VENTRICULAR TACHYCARDIA 21 0.0013
546 EUPHORIC MOOD 13 0.0013
547 BRAIN OEDEMA 16 0.0013
548 VENTRICULAR FIBRILLATION 14 0.0013
549 RENAL CYST 10 0.0013
550 SPINAL OSTEOARTHRITIS 11 0.0013
551 TACHYPNOEA 17 0.0012
552 DRUG TOXICITY 17 0.0012
553 VISUAL FIELD DEFECT 9 0.0012
554 MAJOR DEPRESSION 9 0.0012
555 ANGINA UNSTABLE 8 0.0012
556 SUDDEN DEATH 13 0.0012
557 CORONARY ARTERY DISEASE 37 0.0012
558 TENDON RUPTURE 15 0.0012
559 PAIN 744 0.0012
560 HYPERKALAEMIA 42 0.0012
561 RESPIRATORY DISTRESS 33 0.0012
562 HEPATIC ENZYME INCREASED 81 0.0012
563 TREATMENT FAILURE 98 0.0012
564 TOOTH FRACTURE 13 0.0012
565 ORAL HERPES 23 0.0012
566 IMPAIRED WORK ABILITY 25 0.0012
567 ERECTILE DYSFUNCTION 30 0.0012
568 PSEUDOMONAS INFECTION 10 0.0012
569 COMA 55 0.0012
570 UPPER LIMB FRACTURE 23 0.0012
571 ELECTROCARDIOGRAM ABNORMAL 9 0.0011
572 FOLLICULITIS 12 0.0011
573 CYTOMEGALOVIRUS INFECTION 19 0.0011
574 MYOCARDIAL ISCHAEMIA 13 0.0011
575 DRUG SCREEN POSITIVE 9 0.0011
576 HYPERCALCAEMIA 14 0.0011
577 PURPURA 10 0.0011
578 DIABETES MELLITUS INADEQUATE CONTROL 20 0.0011
579 ABNORMAL DREAMS 31 0.0011
580 HEMIPARESIS 19 0.0011
581 EPSTEIN-BARR VIRUS INFECTION 7 0.0011
582 THROMBOCYTOPENIA 125 0.0011
583 BLOOD POTASSIUM INCREASED 18 0.0011
584 LOWER LIMB FRACTURE 21 0.0011
585 PNEUMONIA BACTERIAL 10 0.0011
586 HIP FRACTURE 35 0.0011
587 PERSONALITY CHANGE 10 0.0011
588 NOCTURIA 13 0.0011
589 LYMPHOPENIA 15 0.0011
590 SEPTIC SHOCK 46 0.0011
591 SUBDURAL HAEMATOMA 15 0.0010
592 MELAENA 23 0.0010
593 LEUKOPENIA 52 0.0010
594 GYNAECOMASTIA 32 0.0010
595 ELECTROLYTE IMBALANCE 12 0.0010
596 NEUROPATHY PERIPHERAL 98 0.0010
597 INTENTIONAL PRODUCT USE ISSUE 90 0.0010
598 GASTRITIS 27 0.0010
599 IMMUNOSUPPRESSION 9 0.0010
600 CARDIOMYOPATHY 15 0.0010
601 ATAXIA 12 0.0010
602 MYOCARDIAL INFARCTION 176 0.0010
603 MOUTH ULCERATION 21 0.0010
604 OEDEMA 54 0.0010
605 PYREXIA 344 0.0010
606 DEPRESSED MOOD 52 0.0010
607 MOBILITY DECREASED 70 0.0010
608 AGRANULOCYTOSIS 18 0.0010
609 ERYTHEMA MULTIFORME 9 0.0010
610 BACTERIAL INFECTION 18 0.0010
611 ACUTE RESPIRATORY DISTRESS SYNDROME 17 0.0010
612 HYPERGLYCAEMIA 35 0.0010
613 BONE PAIN 56 0.0010
614 MYALGIA 162 0.0010
615 GOUT 17 0.0009
616 MUSCLE ATROPHY 12 0.0009
617 GLAUCOMA 18 0.0009
618 CHROMATURIA 21 0.0009
619 GASTROINTESTINAL DISORDER 83 0.0009
620 EXTRAPYRAMIDAL DISORDER 23 0.0009
621 HAEMODYNAMIC INSTABILITY 7 0.0009
622 ACIDOSIS 7 0.0009
623 HAEMOGLOBIN DECREASED 94 0.0009
624 OESOPHAGITIS 10 0.0009
625 GAIT DISTURBANCE 174 0.0009
626 PHOTOSENSITIVITY REACTION 15 0.0009
627 PARALYSIS 13 0.0009
628 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 7 0.0009
629 STEVENS-JOHNSON SYNDROME 20 0.0009
630 OSTEOARTHRITIS 38 0.0009
631 LOSS OF LIBIDO 8 0.0009
632 HERPES ZOSTER 51 0.0009
633 RESPIRATORY FAILURE 64 0.0009
634 GRAND MAL CONVULSION 8 0.0009
635 PULMONARY HYPERTENSION 18 0.0009
636 BLOOD CHOLESTEROL INCREASED 40 0.0009
637 NEUROTOXICITY 15 0.0009
638 DIARRHOEA HAEMORRHAGIC 8 0.0009
639 ENCEPHALOPATHY 21 0.0009
640 SEXUAL DYSFUNCTION 10 0.0009
641 HYPONATRAEMIA 48 0.0009
642 ANGINA PECTORIS 24 0.0008
643 HYPERTHYROIDISM 12 0.0008
644 CONVULSION 47 0.0008
645 VERTIGO 50 0.0008
646 SEPSIS 91 0.0008
647 POLLAKIURIA 34 0.0008
648 GENERALISED OEDEMA 10 0.0008
649 ARRHYTHMIA 38 0.0008
650 CORONARY ARTERY OCCLUSION 11 0.0008
651 MUCOSAL INFLAMMATION 21 0.0008
652 DRUG-INDUCED LIVER INJURY 25 0.0008
653 GENERAL PHYSICAL HEALTH DETERIORATION 92 0.0008
654 GASTROOESOPHAGEAL REFLUX DISEASE 64 0.0008
655 RESTLESSNESS 29 0.0008
656 ADVERSE EVENT 73 0.0008
657 MANIA 13 0.0008
658 STAPHYLOCOCCAL INFECTION 26 0.0008
659 ABDOMINAL PAIN 183 0.0008
660 COAGULOPATHY 13 0.0008
661 VENTRICULAR EXTRASYSTOLES 8 0.0008
662 EYE DISCHARGE 8 0.0008
663 PETECHIAE 8 0.0008
664 CARDIOGENIC SHOCK 11 0.0008
665 ASTHENIA 287 0.0008
666 BACTERAEMIA 9 0.0008
667 HYPOKINESIA 11 0.0008
668 PNEUMOTHORAX 12 0.0008
669 DEFORMITY 7 0.0007
670 ANGIOEDEMA 33 0.0007
671 BREAST CANCER METASTATIC 8 0.0007
672 INTENTIONAL SELF-INJURY 15 0.0007
673 FEBRILE NEUTROPENIA 49 0.0007
674 UNRESPONSIVE TO STIMULI 19 0.0007
675 BRADYCARDIA 39 0.0007
676 GALLBLADDER DISORDER 13 0.0007
677 SLEEP DISORDER 51 0.0007
678 HYPERTENSION 153 0.0007
679 DRUG DISPENSING ERROR 11 0.0007
680 MEDICATION ERROR 40 0.0007
681 RASH PAPULAR 16 0.0007
682 BLOOD CALCIUM DECREASED 8 0.0007
683 CANDIDA INFECTION 12 0.0007
684 VOMITING 334 0.0007
685 FEMUR FRACTURE 22 0.0007
686 HAEMATEMESIS 18 0.0007
687 SKIN REACTION 10 0.0007
688 FEAR 19 0.0007
689 NEUTROPENIA 96 0.0007
690 INSOMNIA 186 0.0007
691 CEREBRAL HAEMORRHAGE 25 0.0007
692 CEREBRAL INFARCTION 17 0.0007
693 WEIGHT DECREASED 194 0.0007
694 NIGHTMARE 24 0.0007
695 SKIN LESION 19 0.0007
696 NODULE 9 0.0007
697 ORTHOSTATIC HYPOTENSION 12 0.0007
698 ABASIA 17 0.0007
699 DISTURBANCE IN ATTENTION 37 0.0007
700 SOPOR 9 0.0007
701 IMPAIRED HEALING 22 0.0007
702 MUSCLE RIGIDITY 8 0.0007
703 DERMATITIS 14 0.0007
704 SUICIDE ATTEMPT 40 0.0007
705 NIGHT SWEATS 21 0.0007
706 ROAD TRAFFIC ACCIDENT 27 0.0006
707 MASS 9 0.0006
708 BIPOLAR DISORDER 7 0.0006
709 PULMONARY EMBOLISM 61 0.0006
710 TASTE DISORDER 13 0.0006
711 RASH 277 0.0006
712 DENTAL CARIES 7 0.0006
713 ROTATOR CUFF SYNDROME 8 0.0006
714 ANOSMIA 9 0.0006
715 PULMONARY ARTERIAL HYPERTENSION 9 0.0006
716 HAEMATOMA 16 0.0006
717 IRRITABILITY 37 0.0006
718 SWELLING FACE 40 0.0006
719 DERMATITIS CONTACT 7 0.0006
720 DYSARTHRIA 23 0.0006
721 HAEMATOCRIT DECREASED 12 0.0006
722 OEDEMA PERIPHERAL 73 0.0006
723 HYPOGLYCAEMIA 29 0.0006
724 CARDIO-RESPIRATORY ARREST 25 0.0006
725 WITHDRAWAL SYNDROME 25 0.0006
726 NAUSEA 468 0.0006
727 EPILEPSY 18 0.0006
728 CIRCULATORY COLLAPSE 10 0.0006
729 TOXICITY TO VARIOUS AGENTS 99 0.0006
730 BLOOD SODIUM DECREASED 11 0.0006
731 DISORIENTATION 23 0.0006
732 FEELING JITTERY 11 0.0006
733 LABORATORY TEST ABNORMAL 17 0.0006
734 RESPIRATORY TRACT INFECTION 15 0.0006
735 PLATELET COUNT DECREASED 61 0.0006
736 CYANOSIS 9 0.0006
737 ACUTE RESPIRATORY FAILURE 11 0.0006
738 DEHYDRATION 76 0.0006
739 SKIN DISORDER 19 0.0006
740 EATING DISORDER 12 0.0006
741 SEIZURE 65 0.0006
742 BRONCHOSPASM 8 0.0006
743 DERMATITIS ALLERGIC 7 0.0006
744 DIARRHOEA 358 0.0006
745 OSTEOMYELITIS 10 0.0006
746 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 14 0.0005
747 FATIGUE 419 0.0005
748 BACK PAIN 125 0.0005
749 CHILLS 63 0.0005
750 PRODUCT PREPARATION ERROR 11 0.0005
751 HAEMORRHAGE INTRACRANIAL 8 0.0005
752 SEDATION 14 0.0005
753 MENTAL DISORDER 23 0.0005
754 MUSCULOSKELETAL DISORDER 10 0.0005
755 WEIGHT INCREASED 117 0.0005
756 NO ADVERSE EVENT 94 0.0005
757 TENDONITIS 8 0.0005
758 EJECTION FRACTION DECREASED 8 0.0005
759 COGNITIVE DISORDER 24 0.0005
760 CARDIOVASCULAR DISORDER 13 0.0005
761 LUNG DISORDER 25 0.0005
762 CENTRAL NERVOUS SYSTEM LESION 7 0.0005
763 DRUG INTOLERANCE 49 0.0005
764 THIRST 9 0.0005
765 OBESITY 8 0.0005
766 SCIATICA 8 0.0005
767 PNEUMONIA 162 0.0005
768 INFLUENZA LIKE ILLNESS 41 0.0005
769 DEAFNESS 13 0.0005
770 NEURALGIA 12 0.0005
771 LIP SWELLING 16 0.0005
772 DYSPNOEA EXERTIONAL 18 0.0005
773 AMNESIA 31 0.0005
774 HYPOCALCAEMIA 9 0.0005
775 MUSCULAR WEAKNESS 54 0.0005
776 BLOOD URINE PRESENT 9 0.0005
777 PRURITUS 182 0.0005
778 CARDIAC FAILURE 38 0.0005
779 ANGER 16 0.0005
780 DRUG WITHDRAWAL SYNDROME NEONATAL 7 0.0005
781 COLON CANCER 7 0.0005
782 MENTAL STATUS CHANGES 13 0.0005
783 DYSTONIA 9 0.0005
784 APHASIA 14 0.0005
785 AGITATION 34 0.0005
786 PRURITUS GENERALISED 10 0.0005
787 DYSURIA 17 0.0005
788 ABDOMINAL DISTENSION 48 0.0005
789 INTERVERTEBRAL DISC PROTRUSION 10 0.0005
790 DRUG ADMINISTRATION ERROR 14 0.0005
791 PRESYNCOPE 11 0.0005
792 CARDIAC ARREST 37 0.0004
793 TYPE 2 DIABETES MELLITUS 15 0.0004
794 LEUKOCYTOSIS 8 0.0004
795 BODY TEMPERATURE INCREASED 9 0.0004
796 DECREASED APPETITE 102 0.0004
797 LOSS OF CONSCIOUSNESS 56 0.0004
798 DYSPEPSIA 43 0.0004
799 BLOOD PRESSURE DECREASED 29 0.0004
800 PERITONITIS 9 0.0004
801 PERICARDIAL EFFUSION 10 0.0004
802 CONJUNCTIVITIS 8 0.0004
803 PHOTOPHOBIA 8 0.0004
804 GENERALISED TONIC-CLONIC SEIZURE 7 0.0004
805 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 22 0.0004
806 CONFUSIONAL STATE 68 0.0004
807 INCREASED APPETITE 8 0.0004
808 ALTERED STATE OF CONSCIOUSNESS 9 0.0004
809 HYPERSENSITIVITY 77 0.0004
810 C-REACTIVE PROTEIN INCREASED 15 0.0004
811 SYNCOPE 41 0.0004
812 KIDNEY INFECTION 8 0.0004
813 LIVER INJURY 10 0.0004
814 RASH PRURITIC 22 0.0004
815 DEPRESSED LEVEL OF CONSCIOUSNESS 16 0.0004
816 ACTIVITIES OF DAILY LIVING IMPAIRED 8 0.0004
817 AGEUSIA 10 0.0004
818 HYPOAESTHESIA 60 0.0004
819 LETHARGY 23 0.0004
820 AGGRESSION 20 0.0004
821 THROMBOSIS 32 0.0004
822 RASH ERYTHEMATOUS 19 0.0004
823 COLITIS 15 0.0004
824 TACHYCARDIA 35 0.0004
825 SKIN IRRITATION 18 0.0004
826 VAGINAL HAEMORRHAGE 17 0.0004
827 PRODUCT USE IN UNAPPROVED INDICATION 97 0.0004
828 VISUAL ACUITY REDUCED 13 0.0004
829 DIZZINESS 195 0.0004
830 VIRAL INFECTION 13 0.0004
831 OVERDOSE 84 0.0004
832 CHEST PAIN 72 0.0004
833 WHITE BLOOD CELL COUNT DECREASED 42 0.0004
834 DRUG ABUSE 32 0.0004
835 HEADACHE 241 0.0004
836 PAIN IN EXTREMITY 112 0.0004
837 DISEASE RECURRENCE 18 0.0004
838 RECTAL HAEMORRHAGE 16 0.0004
839 ARTHRALGIA 154 0.0004
840 PARAESTHESIA 58 0.0004
841 EYE DISORDER 12 0.0004
842 STOMATITIS 22 0.0004
843 GLYCOSYLATED HAEMOGLOBIN INCREASED 9 0.0004
844 ABDOMINAL PAIN LOWER 9 0.0004
845 SOMNOLENCE 71 0.0004
846 INTERNATIONAL NORMALISED RATIO INCREASED 10 0.0004
847 HYPOTENSION 70 0.0003
848 CEREBROVASCULAR ACCIDENT 59 0.0003
849 SKIN DISCOLOURATION 16 0.0003
850 SKIN ULCER 9 0.0003
851 SHOCK 8 0.0003
852 MOOD SWINGS 11 0.0003
853 DRY SKIN 46 0.0003
854 DYSPNOEA 195 0.0003
855 RASH MACULAR 12 0.0003
856 FEELING HOT 21 0.0003
857 CONDITION AGGRAVATED 104 0.0003
858 INJURY 24 0.0003
859 DEEP VEIN THROMBOSIS 22 0.0003
860 OXYGEN SATURATION DECREASED 19 0.0003
861 RESPIRATORY DISORDER 10 0.0003
862 MALAISE 146 0.0003
863 WRONG TECHNIQUE IN DRUG USAGE PROCESS 12 0.0003
864 CRYING 12 0.0003
865 MOOD ALTERED 9 0.0003
866 RESPIRATORY ARREST 9 0.0003
867 INFECTION 47 0.0003
868 BLISTER 18 0.0003
869 SKIN EXFOLIATION 27 0.0003
870 DYSKINESIA 13 0.0003
871 CELLULITIS 16 0.0003
872 URTICARIA 53 0.0003
873 RED BLOOD CELL COUNT DECREASED 9 0.0003
874 HYPOXIA 11 0.0003
875 PLEURAL EFFUSION 19 0.0003
876 INTENTIONAL OVERDOSE 20 0.0003
877 HYPERHIDROSIS 40 0.0003
878 MUSCULOSKELETAL PAIN 16 0.0003
879 HALLUCINATION 23 0.0003
880 COMPLETED SUICIDE 25 0.0003
881 DYSGEUSIA 22 0.0003
882 LUNG NEOPLASM MALIGNANT 12 0.0003
883 EMOTIONAL DISORDER 9 0.0003
884 BLOOD GLUCOSE INCREASED 55 0.0003
885 DIABETIC KETOACIDOSIS 7 0.0003
886 TREMOR 48 0.0003
887 FEELING COLD 8 0.0003
888 NECK PAIN 16 0.0003
889 HEART RATE DECREASED 10 0.0003
890 FLATULENCE 16 0.0003
891 EPISTAXIS 21 0.0003
892 MOVEMENT DISORDER 9 0.0003
893 HAEMORRHAGE 29 0.0003
894 ERYTHEMA 57 0.0003
895 ALOPECIA 54 0.0003
896 PANIC ATTACK 10 0.0003
897 SINUSITIS 28 0.0003
898 INFLAMMATION 14 0.0003
899 URINARY INCONTINENCE 8 0.0003
900 URINARY TRACT INFECTION 46 0.0003
901 INTERSTITIAL LUNG DISEASE 13 0.0003
902 ECZEMA 14 0.0003
903 ABDOMINAL PAIN UPPER 55 0.0003
904 THERAPY NON-RESPONDER 12 0.0003
905 BLOOD POTASSIUM DECREASED 8 0.0003
906 DELIRIUM 9 0.0003
907 BRONCHITIS 19 0.0003
908 NEOPLASM MALIGNANT 17 0.0003
909 OFF LABEL USE 222 0.0003
910 INTENTIONAL PRODUCT MISUSE 22 0.0003
911 CYSTITIS 8 0.0003
912 HYPOTHYROIDISM 8 0.0003
913 THERAPEUTIC RESPONSE DECREASED 15 0.0002
914 INJECTION SITE REACTION 17 0.0002
915 ACCIDENTAL OVERDOSE 9 0.0002
916 BLINDNESS 10 0.0002
917 COUGH 68 0.0002
918 DRUG DOSE OMISSION 40 0.0002
919 LOWER RESPIRATORY TRACT INFECTION 11 0.0002
920 HOSPITALISATION 37 0.0002
921 PALPITATIONS 28 0.0002
922 CARDIAC FAILURE CONGESTIVE 19 0.0002
923 OROPHARYNGEAL PAIN 21 0.0002
924 PULMONARY OEDEMA 10 0.0002
925 HEART RATE INCREASED 22 0.0002
926 NASAL CONGESTION 13 0.0002
927 ASTHMA 25 0.0002
928 NEUTROPHIL COUNT DECREASED 9 0.0002
929 DEATH 189 0.0002
930 TINNITUS 10 0.0002
931 MUSCULOSKELETAL STIFFNESS 19 0.0002
932 ARTHRITIS 17 0.0002
933 INTESTINAL OBSTRUCTION 8 0.0002
934 UNEVALUABLE EVENT 16 0.0002
935 MEMORY IMPAIRMENT 29 0.0002
936 FALL 70 0.0002
937 WHITE BLOOD CELL COUNT INCREASED 8 0.0002
938 DYSPHONIA 12 0.0002
939 GASTRIC DISORDER 7 0.0002
940 ADVERSE DRUG REACTION 18 0.0002
941 DRY MOUTH 16 0.0002
942 UPPER RESPIRATORY TRACT INFECTION 9 0.0002
943 DRUG WITHDRAWAL SYNDROME 17 0.0002
944 CARDIAC DISORDER 18 0.0002
945 GASTROINTESTINAL HAEMORRHAGE 16 0.0002
946 NERVOUSNESS 10 0.0002
947 OCULAR HYPERAEMIA 9 0.0002
948 VISION BLURRED 26 0.0002
949 PRODUCTIVE COUGH 9 0.0002
950 RHINORRHOEA 12 0.0002
951 BURNING SENSATION 13 0.0002
952 MUSCLE SPASMS 34 0.0002
953 BALANCE DISORDER 16 0.0002
954 SWELLING 17 0.0002
955 ABDOMINAL DISCOMFORT 30 0.0002
956 MIGRAINE 17 0.0002
957 VISUAL IMPAIRMENT 22 0.0002
958 ABNORMAL BEHAVIOUR 7 0.0002
959 BLOOD PRESSURE INCREASED 27 0.0002
960 ATRIAL FIBRILLATION 17 0.0002
961 SPEECH DISORDER 9 0.0002
962 CONSTIPATION 37 0.0002
963 NASOPHARYNGITIS 31 0.0002
964 ILL-DEFINED DISORDER 10 0.0002
965 DISCOMFORT 10 0.0002
966 DRUG INEFFECTIVE 216 0.0002
967 HAEMATOCHEZIA 9 0.0002
968 DRUG DEPENDENCE 25 0.0002
969 FEELING ABNORMAL 37 0.0002
970 INFLUENZA 17 0.0002
971 WHEEZING 9 0.0002
972 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8 0.0001
973 INCORRECT DOSE ADMINISTERED 33 0.0001
974 JOINT SWELLING 17 0.0001
975 ACNE 10 0.0001
976 DRUG EFFECT DECREASED 7 0.0001
977 DEPENDENCE 7 0.0001
978 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 9 0.0001
979 SKIN BURNING SENSATION 8 0.0001
980 UNDERDOSE 8 0.0001
981 FLUSHING 11 0.0001
982 CHEST DISCOMFORT 11 0.0001
983 PROSTATE CANCER 8 0.0001
984 PRODUCT STORAGE ERROR 8 0.0001
985 PRODUCT QUALITY ISSUE 12 0.0001
986 PERIPHERAL SWELLING 13 0.0001
987 PRODUCT USE ISSUE 15 0.0001
988 PSORIASIS 10 0.0001
989 DISEASE PROGRESSION 8 0.0001
990 COVID-19 9 0.0001
991 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 8 0.0000
992 INJECTION SITE PAIN 11 0.0000